C OSBORNE's research topics

C OSBORNE

Concepts (725)

Back to Profile

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name	Number of Publications	Most Recent Publication	Publications by All Authors	Concept Score	Why?
Breast Neoplasms	249	2015	2649	8.010	Why?
Receptors, Estrogen	114	2015	723	5.190	Why?
Tamoxifen	74	2011	350	4.740	Why?
Antineoplastic Agents, Hormonal	48	2011	256	4.240	Why?
Poaceae	9	2025	15	2.010	Why?
Antineoplastic Combined Chemotherapy Protocols	48	2015	1356	1.950	Why?
Receptors, Progesterone	46	2012	680	1.870	Why?
Estrogen Antagonists	23	2011	92	1.640	Why?
Drug Resistance, Neoplasm	24	2011	826	1.420	Why?
Neoplasms, Hormone-Dependent	19	2011	92	1.390	Why?
Biomarkers, Tumor	30	2013	1617	1.320	Why?
Photosynthesis	5	2025	12	1.290	Why?
Estradiol	22	2010	481	1.220	Why?
Antineoplastic Agents	25	2015	1811	1.030	Why?
Quinazolines	7	2015	181	0.960	Why?
Estrogen Receptor Modulators	10	2005	39	0.840	Why?
Plant Leaves	5	2025	55	0.780	Why?
DNA, Neoplasm	18	2013	286	0.780	Why?
Aromatase Inhibitors	10	2015	78	0.760	Why?
Selective Estrogen Receptor Modulators	7	2010	51	0.760	Why?
Water	3	2025	190	0.750	Why?
Growth Substances	9	2004	102	0.730	Why?
Antibodies, Monoclonal, Humanized	5	2015	580	0.720	Why?
Cyclophosphamide	34	2011	442	0.690	Why?
Female	215	2015	71214	0.680	Why?
ErbB Receptors	16	2011	296	0.650	Why?
Chemotherapy, Adjuvant	25	2010	393	0.640	Why?
Estrogens	19	2006	436	0.620	Why?
Gene Expression Regulation, Neoplastic	22	2009	2003	0.620	Why?
Neoplasm Metastasis	22	2015	713	0.600	Why?
Nitriles	8	2015	165	0.580	Why?
Lymphatic Metastasis	34	2009	433	0.570	Why?
Cell Division	35	2003	731	0.560	Why?
Humans	265	2015	131759	0.560	Why?
Doxorubicin	22	2011	301	0.560	Why?
Tumor Cells, Cultured	28	2003	989	0.550	Why?
Fluorouracil	29	2010	134	0.520	Why?
Receptor Cross-Talk	5	2011	36	0.520	Why?
Gene Transfer, Horizontal	2	2019	45	0.520	Why?
Disease-Free Survival	30	2010	910	0.520	Why?
Carcinoma	4	2015	283	0.510	Why?
Triazoles	8	2015	144	0.490	Why?
Receptors, Growth Factor	3	2005	36	0.490	Why?
Carbon Dioxide	2	2014	272	0.470	Why?
Prognosis	59	2015	4953	0.470	Why?
Droughts	2	2021	12	0.470	Why?
Plant Proteins	2	2013	89	0.460	Why?
Genes, Plant	2	2019	38	0.430	Why?
Evolution, Molecular	3	2019	657	0.400	Why?
Mice, Nude	24	2008	714	0.400	Why?
Mucin-1	1	2013	34	0.390	Why?
Signal Transduction	21	2011	4683	0.390	Why?
Insulin-Like Growth Factor I	10	2006	323	0.390	Why?
Estrogen Receptor alpha	6	2008	434	0.370	Why?
Clinical Trials as Topic	16	2011	1139	0.360	Why?
Drug Resistance	14	2005	252	0.360	Why?
Immunohistochemistry	16	2010	1610	0.360	Why?
Middle Aged	85	2011	28892	0.350	Why?
Pregnancy Complications, Neoplastic	1	2011	63	0.340	Why?
Aged	67	2011	21259	0.340	Why?
Plants	2	2021	48	0.330	Why?
Survival Analysis	23	2007	1521	0.330	Why?
Lymph Nodes	15	2009	376	0.330	Why?
Receptors, Cell Surface	11	1995	432	0.330	Why?
Adenocarcinoma	9	2009	998	0.330	Why?
Gene Expression Profiling	8	2015	1835	0.320	Why?
Methotrexate	23	2010	342	0.320	Why?
Sirolimus	1	2012	231	0.320	Why?
Prednisone	17	2011	244	0.310	Why?
Repressor Proteins	6	2005	781	0.310	Why?
Lymphoma	4	2011	331	0.310	Why?
Heat-Shock Proteins	5	2011	178	0.300	Why?
Biological Evolution	4	2023	229	0.300	Why?
Climate Change	3	2021	64	0.300	Why?
Trees	2	2019	20	0.290	Why?
Ovariectomy	5	1998	163	0.290	Why?
Adult	71	2011	31700	0.290	Why?
Proportional Hazards Models	13	2009	1405	0.280	Why?
Vincristine	12	2011	194	0.280	Why?
Immunosuppressive Agents	1	2012	667	0.270	Why?
Nuclear Proteins	7	2005	1226	0.270	Why?
Transcription Factors	6	2003	2438	0.270	Why?
Somatomedins	4	1999	33	0.270	Why?
Aged, 80 and over	24	2011	6915	0.260	Why?
Postmenopause	11	2009	149	0.250	Why?
Antibiotics, Antineoplastic	5	2009	125	0.240	Why?
Ploidies	10	2000	35	0.240	Why?
Genes, erbB-1	1	2005	9	0.230	Why?
Trastuzumab	4	2015	148	0.230	Why?
Enzyme Inhibitors	5	2004	566	0.220	Why?
Animals	55	2018	34404	0.220	Why?
Epidermal Growth Factor	6	2004	116	0.220	Why?
Mitogen-Activated Protein Kinases	3	2003	189	0.220	Why?
Antibodies, Monoclonal	10	2011	1010	0.210	Why?
Transcription Factor AP-1	2	2002	112	0.210	Why?
Receptors, Retinoic Acid	2	2003	76	0.210	Why?
Mammary Neoplasms, Experimental	5	1999	237	0.200	Why?
Goserelin	3	2005	4	0.200	Why?
Cell Line	22	2003	2606	0.200	Why?
Combined Modality Therapy	17	2005	1260	0.200	Why?
Neoplasms, Second Primary	1	2005	143	0.200	Why?
Neoplasm Proteins	8	2000	677	0.200	Why?
Adaptation, Physiological	1	2025	261	0.200	Why?
Proto-Oncogene Proteins c-bcl-2	4	1998	173	0.200	Why?
Antineoplastic Agents, Phytogenic	4	2005	102	0.190	Why?
Prostatic Neoplasms	5	1992	1418	0.190	Why?
Treatment Outcome	28	2011	12993	0.190	Why?
Computer Simulation	1	2006	685	0.190	Why?
Ecosystem	2	2020	99	0.190	Why?
Drug Administration Schedule	12	2007	741	0.180	Why?
Insulin-Like Growth Factor II	3	1992	38	0.180	Why?
Tumor Suppressor Protein p53	6	1998	738	0.180	Why?
Carcinoma, Ductal, Breast	4	2010	87	0.180	Why?
Mice	36	2015	18482	0.180	Why?
Genetic Markers	1	2003	605	0.180	Why?
Transforming Growth Factor alpha	4	1994	27	0.180	Why?
Xylem	1	2021	3	0.170	Why?
Phylogeny	4	2020	709	0.170	Why?
Survival Rate	15	2005	2151	0.170	Why?
Acclimatization	1	2021	21	0.170	Why?
Trans-Activators	3	2005	692	0.170	Why?
Transforming Growth Factors	5	1988	18	0.170	Why?
Phenotype	7	2021	4528	0.170	Why?
Transfection	9	2002	960	0.170	Why?
Predictive Value of Tests	14	2010	2298	0.160	Why?
HSP70 Heat-Shock Proteins	2	1998	72	0.160	Why?
Plant Stomata	2	2025	7	0.160	Why?
Taxoids	3	2005	71	0.160	Why?
Neoplasms, Experimental	6	1989	205	0.160	Why?
Genes, erbB-2	3	2011	32	0.160	Why?
Polymorphism, Genetic	4	2010	794	0.160	Why?
Cell Proliferation	6	2011	2483	0.160	Why?
Melphalan	4	2003	44	0.150	Why?
Mitoxantrone	7	1999	29	0.150	Why?
Neoplasm Transplantation	9	2006	361	0.150	Why?
Databases, Factual	2	2021	1224	0.150	Why?
Mesoderm	1	2009	108	0.150	Why?
Domestication	1	2018	4	0.150	Why?
Soil	1	2019	77	0.150	Why?
Crops, Agricultural	1	2018	15	0.150	Why?
Molecular Targeted Therapy	2	2011	388	0.150	Why?
Animals, Domestic	1	2018	37	0.150	Why?
Neoplasm, Residual	1	2009	136	0.140	Why?
Peptides	5	1988	835	0.140	Why?
Nuclear Matrix-Associated Proteins	3	2005	18	0.140	Why?
Matrix Attachment Region Binding Proteins	3	2005	18	0.140	Why?
Recombinant Fusion Proteins	4	2000	694	0.140	Why?
Carbon	2	2019	94	0.140	Why?
S Phase	8	2000	73	0.140	Why?
Forests	1	2017	14	0.140	Why?
Menopause	10	2003	87	0.140	Why?
Multivariate Analysis	7	2004	1406	0.140	Why?
Disease Progression	11	2011	2221	0.140	Why?
Dose-Response Relationship, Drug	8	2007	1626	0.130	Why?
Anticarcinogenic Agents	2	2010	46	0.130	Why?
Time Factors	18	2010	6280	0.130	Why?
Tetrahydronaphthalenes	2	2010	30	0.130	Why?
Double-Blind Method	7	2010	1638	0.130	Why?
Transcriptome	3	2015	1148	0.130	Why?
Transplantation, Heterologous	8	2006	261	0.130	Why?
Cathepsin D	2	1994	16	0.130	Why?
Drug Evaluation	8	1992	102	0.130	Why?
Neoplasm Invasiveness	6	2010	646	0.130	Why?
Flow Cytometry	9	1999	769	0.130	Why?
Receptors, Steroid	4	1992	172	0.120	Why?
Proto-Oncogene Proteins	4	1994	600	0.120	Why?
Loss of Heterozygosity	3	2001	124	0.120	Why?
Axilla	10	2005	43	0.120	Why?
Blotting, Western	5	2003	1018	0.120	Why?
Protein-Tyrosine Kinases	3	2011	226	0.120	Why?
Oxidative Stress	1	2000	807	0.120	Why?
Neoplasm Recurrence, Local	10	2010	1280	0.120	Why?
Phosphorylation	9	2008	1571	0.120	Why?
Hormones	5	1989	165	0.120	Why?
Superoxide Dismutase	2	2010	179	0.110	Why?
Hematopoietic Cell Growth Factors	2	1991	9	0.110	Why?
Receptors, Somatomedin	6	1999	21	0.110	Why?
Megestrol	2	1997	2	0.110	Why?
Models, Biological	5	2025	1395	0.110	Why?
Neutropenia	2	2010	205	0.110	Why?
Polymerase Chain Reaction	4	2009	1489	0.110	Why?
Insulin	7	1984	1151	0.110	Why?
Neoplastic Cells, Circulating	1	2015	78	0.110	Why?
Immunotoxins	1	1994	22	0.100	Why?
Kinetics	10	1990	1104	0.100	Why?
South Africa	1	2014	104	0.100	Why?
Nursing Assessment	1	1993	21	0.100	Why?
Granulocyte-Macrophage Colony-Stimulating Factor	1	1994	70	0.100	Why?
Gene Expression	5	2002	1502	0.100	Why?
Premenopause	5	2005	38	0.100	Why?
Orientation	1	1993	39	0.100	Why?
Mastectomy	7	2005	75	0.100	Why?
Phosphoproteins	3	2001	430	0.100	Why?
Analysis of Variance	6	1997	955	0.100	Why?
Gene Amplification	3	2011	228	0.100	Why?
Logistic Models	5	2010	1838	0.100	Why?
Air	1	2013	22	0.100	Why?
Histone Deacetylases	2	2005	119	0.100	Why?
Pyrrolidines	2	2010	47	0.100	Why?
Receptor, IGF Type 1	4	2011	93	0.100	Why?
Vinblastine	2	2011	55	0.100	Why?
Tyrphostins	1	1992	13	0.090	Why?
Histone Acetyltransferases	2	2003	224	0.090	Why?
Data Collection	2	1993	372	0.090	Why?
Nurses	1	1993	79	0.090	Why?
Cell Line, Tumor	9	2015	3692	0.090	Why?
Research Personnel	1	1993	139	0.090	Why?
Mice, Inbred BALB C	7	2004	1020	0.090	Why?
Phosphotransferases	1	1992	33	0.090	Why?
Sequence Analysis, Protein	1	2012	48	0.090	Why?
Promoter Regions, Genetic	5	2006	1218	0.090	Why?
Plasmids	2	2002	455	0.090	Why?
Everolimus	1	2012	48	0.090	Why?
Antibodies, Monoclonal, Murine-Derived	1	2011	62	0.090	Why?
Genes, Tumor Suppressor	3	2001	200	0.090	Why?
Phosphotransferases (Alcohol Group Acceptor)	1	1992	79	0.090	Why?
Bleomycin	1	2011	111	0.090	Why?
Dacarbazine	1	2011	93	0.090	Why?
Genetic Vectors	2	1994	901	0.090	Why?
Nuclear Receptor Coactivator 3	2	2003	257	0.090	Why?
Molecular Sequence Data	5	2012	3616	0.090	Why?
Forecasting	3	2005	361	0.090	Why?
Antineoplastic Agents, Alkylating	3	2010	98	0.090	Why?
Activities of Daily Living	1	1993	409	0.080	Why?
Motivation	1	1993	332	0.080	Why?
Fertility Preservation	1	2011	62	0.080	Why?
Osteoporosis, Postmenopausal	1	2010	31	0.080	Why?
Women's Health	1	2012	143	0.080	Why?
Pyridines	1	1992	260	0.080	Why?
Follow-Up Studies	10	2007	5297	0.080	Why?
Paclitaxel	2	2003	134	0.080	Why?
Cell Cycle	7	2006	598	0.080	Why?
Sequence Alignment	1	2012	595	0.080	Why?
Rituximab	1	2011	174	0.080	Why?
Placebos	1	2011	227	0.080	Why?
Quality of Life	4	2002	2115	0.080	Why?
Health Planning Guidelines	1	2010	33	0.080	Why?
Southwestern United States	3	2010	46	0.080	Why?
Amino Acid Sequence	3	2012	2565	0.080	Why?
Metabolic Networks and Pathways	1	2010	193	0.080	Why?
Peroxidase	1	2009	64	0.080	Why?
Transcription, Genetic	3	2008	1398	0.080	Why?
Acronine	1	1989	1	0.070	Why?
Biopsy, Needle	5	2005	216	0.070	Why?
Treatment Failure	4	2010	353	0.070	Why?
Tumor Necrosis Factor-alpha	1	1991	643	0.070	Why?
Guidelines as Topic	1	2010	200	0.070	Why?
Alkaloids	1	1989	36	0.070	Why?
Apoptosis	4	2005	1861	0.070	Why?
Ki-67 Antigen	3	2000	106	0.070	Why?
Nitric Oxide Synthase Type III	1	2009	187	0.070	Why?
Nuclear Receptor Co-Repressor 1	3	2005	51	0.070	Why?
DNA	4	2006	1442	0.070	Why?
Pregnancy Outcome	1	2011	631	0.070	Why?
Disease Models, Animal	6	2015	4685	0.070	Why?
Fractures, Bone	1	2010	207	0.070	Why?
DNA-Binding Proteins	4	2000	1965	0.070	Why?
Drug Screening Assays, Antitumor	3	1994	111	0.070	Why?
Drug-Related Side Effects and Adverse Reactions	1	2011	267	0.070	Why?
Biopsy	7	2009	1252	0.070	Why?
Transcriptional Activation	2	2000	414	0.070	Why?
Cell Nucleus	5	2000	567	0.070	Why?
Chromatography, High Pressure Liquid	4	1994	334	0.070	Why?
Immunologic Factors	1	1989	192	0.070	Why?
Binding, Competitive	3	2000	152	0.070	Why?
Attitude of Health Personnel	1	1993	715	0.070	Why?
Neoadjuvant Therapy	6	2006	407	0.070	Why?
Anthraquinones	2	1985	9	0.070	Why?
United States	12	2010	11812	0.070	Why?
Estrogen Receptor beta	2	2004	77	0.070	Why?
North America	2	2010	257	0.060	Why?
Protein Binding	5	2004	1712	0.060	Why?
Protein Kinase Inhibitors	1	2011	618	0.060	Why?
Receptors, Interleukin	1	2006	37	0.060	Why?
Ligands	4	2004	486	0.060	Why?
Pain Management	1	1989	203	0.060	Why?
Cytosol	3	1997	140	0.060	Why?
Receptors, Somatotropin	1	2006	9	0.060	Why?
Oligonucleotide Array Sequence Analysis	4	2008	1008	0.060	Why?
Benzamides	1	2006	122	0.060	Why?
Glutathione Transferase	2	2010	145	0.060	Why?
Medroxyprogesterone	2	1985	9	0.060	Why?
Anthracenes	6	1991	9	0.060	Why?
Neoplasms	6	2012	2966	0.060	Why?
Human Growth Hormone	1	2006	75	0.060	Why?
MicroRNAs	1	2012	895	0.060	Why?
Decision Making	2	2003	687	0.060	Why?
Carrier Proteins	1	1990	1024	0.060	Why?
Neoplasm Staging	6	2007	1322	0.060	Why?
Plant Transpiration	1	2025	3	0.060	Why?
Tumor Stem Cell Assay	1	1985	34	0.060	Why?
Colony-Forming Units Assay	1	1985	63	0.060	Why?
Mastectomy, Radical	3	2003	9	0.060	Why?
RNA, Messenger	5	2002	2569	0.060	Why?
Drug Approval	1	2005	46	0.060	Why?
Prospective Studies	5	2010	6507	0.060	Why?
p38 Mitogen-Activated Protein Kinases	1	2005	125	0.050	Why?
Insulin-Like Growth Factor Binding Proteins	2	1997	33	0.050	Why?
Proteinuria	1	2005	106	0.050	Why?
Dog Diseases	1	2005	58	0.050	Why?
JNK Mitogen-Activated Protein Kinases	2	2002	85	0.050	Why?
RNA, Neoplasm	4	1990	127	0.050	Why?
In Situ Hybridization	2	1995	452	0.050	Why?
Injections, Intramuscular	1	2004	187	0.050	Why?
Cell Size	1	2023	79	0.050	Why?
Androstenedione	1	2003	15	0.050	Why?
Metallothionein	2	1994	16	0.050	Why?
Nuclear Receptor Coactivator 1	1	2003	162	0.050	Why?
Algorithms	4	2010	1685	0.050	Why?
Homeodomain Proteins	1	2006	568	0.050	Why?
Oncogene Proteins, Viral	2	1994	61	0.050	Why?
Acetyltransferases	1	2003	73	0.050	Why?
Creatinine	1	2005	402	0.050	Why?
Clinical Trials, Phase III as Topic	3	2009	76	0.050	Why?
Genetic Testing	1	2009	1101	0.050	Why?
Chromosomes, Human, Pair 14	2	2001	96	0.050	Why?
Bone Density	2	2010	362	0.050	Why?
Proteins	2	2001	1027	0.050	Why?
Infusions, Intravenous	3	2007	549	0.050	Why?
Genes, Dominant	1	2003	252	0.050	Why?
Breast	4	2003	216	0.050	Why?
Oncogene Proteins	1	2003	135	0.050	Why?
Lymphoma, Large B-Cell, Diffuse	4	1983	164	0.050	Why?
Structure-Activity Relationship	2	2000	579	0.050	Why?
Cisplatin	4	2009	286	0.050	Why?
Statistics as Topic	3	1999	244	0.050	Why?
Immunoenzyme Techniques	2	2004	237	0.050	Why?
Research	3	1995	269	0.050	Why?
Retrospective Studies	10	2009	17662	0.040	Why?
Administration, Oral	1	2004	709	0.040	Why?
Plant Physiological Phenomena	1	2021	7	0.040	Why?
Mastectomy, Segmental	2	2004	39	0.040	Why?
Hyperbaric Oxygenation	2	1973	20	0.040	Why?
Salvage Therapy	1	2003	178	0.040	Why?
Stereoisomerism	2	1992	116	0.040	Why?
Odds Ratio	3	2010	1235	0.040	Why?
Randomized Controlled Trials as Topic	4	2009	1253	0.040	Why?
BRCA1 Protein	2	1999	83	0.040	Why?
Phorbols	1	1981	5	0.040	Why?
Radioimmunoassay	2	1991	99	0.040	Why?
Nucleoside-Diphosphate Kinase	1	2001	4	0.040	Why?
Climate	1	2021	26	0.040	Why?
Biophysical Phenomena	1	2021	40	0.040	Why?
Australia	1	2021	176	0.040	Why?
Phorbol Esters	1	1981	21	0.040	Why?
Monomeric GTP-Binding Proteins	1	2001	28	0.040	Why?
Chloramphenicol O-Acetyltransferase	1	2000	60	0.040	Why?
Azacitidine	1	2001	51	0.040	Why?
Enhancer Elements, Genetic	1	2002	274	0.040	Why?
Chromosomes, Human, Pair 19	1	2001	60	0.040	Why?
Proto-Oncogene Proteins c-jun	1	2000	35	0.040	Why?
Cold Temperature	1	2021	81	0.040	Why?
Pentose Phosphate Pathway	1	2000	44	0.040	Why?
Muscle Proteins	1	2003	404	0.040	Why?
Proto-Oncogene Proteins c-akt	2	2008	482	0.040	Why?
Plant Dispersal	1	2020	1	0.040	Why?
Lipid Peroxidation	1	2000	91	0.040	Why?
Glucocorticoids	3	1979	350	0.040	Why?
Risk Factors	10	2010	10961	0.040	Why?
Urokinase-Type Plasminogen Activator	2	1997	34	0.040	Why?
Carbon Sequestration	1	2019	6	0.040	Why?
Risk Assessment	4	2010	3696	0.040	Why?
Aneuploidy	1	2000	141	0.040	Why?
Reverse Transcriptase Polymerase Chain Reaction	3	2009	1236	0.040	Why?
Plasminogen Activator Inhibitor 1	2	1997	50	0.040	Why?
Claudin-1	1	2009	19	0.040	Why?
Insulin Antagonists	1	1979	4	0.040	Why?
Protein Kinases	2	2008	322	0.040	Why?
CD24 Antigen	1	2009	31	0.040	Why?
Gene Expression Regulation, Plant	1	2019	62	0.040	Why?
Molecular Weight	2	1990	297	0.040	Why?
Genome	2	2019	473	0.040	Why?
Leukocyte Count	2	2009	248	0.040	Why?
Hyaluronan Receptors	1	2009	65	0.040	Why?
Gene Dosage	2	2008	439	0.040	Why?
Pregnancy	2	2011	7576	0.040	Why?
Patient Selection	3	2009	726	0.040	Why?
Breast Neoplasms, Male	1	1998	17	0.040	Why?
Cyclins	1	1999	94	0.040	Why?
Depression, Chemical	2	2000	35	0.040	Why?
Down-Regulation	3	2005	659	0.040	Why?
Epithelium	1	2009	343	0.040	Why?
Antimetabolites, Antineoplastic	3	2009	187	0.030	Why?
Injections, Intraperitoneal	2	1989	66	0.030	Why?
Hormone Antagonists	1	1998	45	0.030	Why?
Medical Oncology	2	2010	238	0.030	Why?
Aminoglutethimide	1	1997	3	0.030	Why?
Immunoblotting	2	2004	291	0.030	Why?
Mammography	2	2010	131	0.030	Why?
DNA Replication	2	1989	359	0.030	Why?
Centrifugation	1	1997	18	0.030	Why?
Cell Survival	3	1989	854	0.030	Why?
Endometrial Neoplasms	1	1998	110	0.030	Why?
Cytodiagnosis	1	1997	20	0.030	Why?
Recombinant Proteins	2	1991	1316	0.030	Why?
Cell Movement	1	2001	886	0.030	Why?
Cell Membrane	1	2009	464	0.030	Why?
Lung Neoplasms	4	2015	1542	0.030	Why?
Drug Synergism	2	2008	240	0.030	Why?
Telomerase	1	1997	157	0.030	Why?
Nucleic Acids	2	2012	26	0.030	Why?
DNA Primers	4	1999	609	0.030	Why?
Age Factors	3	2007	2872	0.030	Why?
Kidney Failure, Chronic	1	2005	941	0.030	Why?
Thymidine	3	1982	52	0.030	Why?
Receptor, Insulin	5	1999	64	0.030	Why?
Hydrocortisone	1	1997	224	0.030	Why?
Phosphatidylinositol 3-Kinases	1	2008	344	0.030	Why?
Chromosomal Proteins, Non-Histone	1	1997	205	0.030	Why?
Testosterone	1	1982	604	0.030	Why?
Cytoplasm	2	1995	254	0.030	Why?
Polyethylene Glycols	1	1997	245	0.030	Why?
TOR Serine-Threonine Kinases	1	2008	427	0.030	Why?
DNA Damage	1	1999	527	0.030	Why?
Societies, Medical	2	2010	796	0.030	Why?
Male	15	2005	65274	0.030	Why?
Quality-Adjusted Life Years	1	1996	126	0.030	Why?
Interphase	2	1987	35	0.030	Why?
Leukopenia	3	1985	45	0.030	Why?
Hyperplasia	3	2005	189	0.030	Why?
Mutation	4	2003	6194	0.030	Why?
Chromosome Deletion	1	1998	652	0.030	Why?
Remission Induction	2	1998	309	0.030	Why?
Culture Media, Conditioned	1	1994	83	0.030	Why?
Cell Transformation, Neoplastic	2	1998	611	0.030	Why?
Hematopoietic Stem Cell Transplantation	1	2003	1263	0.030	Why?
Chi-Square Distribution	1	1996	570	0.030	Why?
Clone Cells	3	1985	171	0.030	Why?
Palliative Care	1	1998	446	0.030	Why?
Heterografts	1	2015	195	0.030	Why?
DNA Methylation	1	2001	1087	0.030	Why?
Stimulation, Chemical	1	1994	43	0.030	Why?
Bone Neoplasms	3	2000	444	0.030	Why?
Isomerism	1	1994	25	0.030	Why?
Follicle Stimulating Hormone	1	1994	188	0.030	Why?
Hematologic Tests	1	1994	36	0.030	Why?
Cloning, Molecular	2	1993	786	0.030	Why?
Rats	6	2000	3460	0.030	Why?
Castration	3	1985	31	0.030	Why?
Quality Control	1	1993	118	0.030	Why?
Protein Biosynthesis	1	1996	580	0.020	Why?
Vitamin E Deficiency	1	1973	2	0.020	Why?
Peroxides	1	1973	7	0.020	Why?
Dexamethasone	3	1980	262	0.020	Why?
Base Sequence	4	2000	2783	0.020	Why?
Methemoglobinemia	1	1973	9	0.020	Why?
Recurrence	3	2009	1483	0.020	Why?
Chromosome Aberrations	1	1995	577	0.020	Why?
Hemolysis	1	1973	86	0.020	Why?
Up-Regulation	2	2005	832	0.020	Why?
Xenograft Model Antitumor Assays	2	2008	999	0.020	Why?
Erythrocytes	1	1973	191	0.020	Why?
RNA Stability	1	2012	75	0.020	Why?
Carcinoma in Situ	1	1992	72	0.020	Why?
Carcinoma, Intraductal, Noninfiltrating	1	1992	69	0.020	Why?
Membrane Proteins	1	2009	1610	0.020	Why?
Antisense Elements (Genetics)	1	1991	4	0.020	Why?
Gene Expression Regulation	3	1998	2353	0.020	Why?
Electrophoresis, Agar Gel	1	1991	40	0.020	Why?
Templates, Genetic	1	1991	54	0.020	Why?
Oxidoreductases, N-Demethylating	1	2010	9	0.020	Why?
Burnout, Professional	1	1993	131	0.020	Why?
Cytochrome P-450 CYP2B6	1	2010	15	0.020	Why?
Inactivation, Metabolic	1	2010	26	0.020	Why?
Glutathione S-Transferase pi	1	2010	25	0.020	Why?
Aryl Hydrocarbon Hydroxylases	1	2010	40	0.020	Why?
Diethylstilbestrol	1	1990	42	0.020	Why?
Angiogenesis Inhibitors	1	2011	111	0.020	Why?
Sex Hormone-Binding Globulin	1	2010	50	0.020	Why?
Cytochrome P-450 CYP3A	1	2010	51	0.020	Why?
Orchiectomy	1	1990	52	0.020	Why?
False Negative Reactions	1	2010	88	0.020	Why?
Insulin Receptor Substrate Proteins	2	2001	72	0.020	Why?
Bone Density Conservation Agents	1	2010	58	0.020	Why?
Alanine	1	1991	163	0.020	Why?
False Positive Reactions	1	2010	142	0.020	Why?
Cohort Studies	3	2006	5122	0.020	Why?
Uridine	2	1980	31	0.020	Why?
Cancer Vaccines	1	2011	191	0.020	Why?
Research Design	2	2005	723	0.020	Why?
Lipid Metabolism	1	1973	371	0.020	Why?
Karyotyping	2	1987	314	0.020	Why?
Primary Prevention	1	2010	175	0.020	Why?
Patient Care Team	1	1993	557	0.020	Why?
Cells, Cultured	7	1987	2969	0.020	Why?
Microfilament Proteins	2	2003	272	0.020	Why?
Buserelin	1	1989	1	0.020	Why?
Sensitivity and Specificity	2	2010	2146	0.020	Why?
Oncogenes	1	1989	164	0.020	Why?
Transforming Growth Factor beta	1	1992	463	0.020	Why?
Solubility	1	1989	118	0.020	Why?
Cell Adhesion	1	1989	312	0.020	Why?
Pilot Projects	3	1999	1457	0.020	Why?
Bone Marrow Transplantation	1	1991	590	0.020	Why?
Affinity Labels	1	1988	10	0.020	Why?
Biological Availability	1	1989	140	0.020	Why?
Linear Models	1	1990	695	0.020	Why?
Adolescent	3	2005	20987	0.020	Why?
Gene Frequency	1	2010	750	0.020	Why?
CHO Cells	2	2000	149	0.020	Why?
3T3 Cells	2	2000	121	0.020	Why?
Cricetinae	2	2000	367	0.020	Why?
Culture Techniques	2	1978	75	0.020	Why?
Nausea	2	1985	83	0.020	Why?
Fatty Acids	3	1983	377	0.020	Why?
Agar	1	1987	17	0.020	Why?
Biological Products	1	1989	144	0.020	Why?
Microscopy, Electron	1	1987	314	0.020	Why?
Choline Dehydrogenase	1	2006	2	0.020	Why?
Tissue Distribution	2	1997	366	0.020	Why?
Receptors, Interleukin-17	1	2006	7	0.020	Why?
Adrenalectomy	3	1978	40	0.020	Why?
Kaplan-Meier Estimate	1	2009	1078	0.020	Why?
Injections, Subcutaneous	1	1987	133	0.020	Why?
Culture Media	2	1984	175	0.020	Why?
Mitosis	1	1987	190	0.020	Why?
Delayed-Action Preparations	1	1987	118	0.020	Why?
Response Elements	1	2006	99	0.020	Why?
Probability	1	2007	310	0.020	Why?
Evidence-Based Medicine	1	2010	645	0.020	Why?
Ethics, Medical	1	1989	399	0.020	Why?
Statistics, Nonparametric	1	2007	432	0.010	Why?
Immunologic Techniques	1	1985	8	0.010	Why?
Liver Neoplasms	3	2003	1387	0.010	Why?
Endpoint Determination	1	2005	56	0.010	Why?
Health Status Disparities	1	2009	277	0.010	Why?
Chemoprevention	1	2005	51	0.010	Why?
Random Allocation	4	1989	423	0.010	Why?
Phenylalanine	1	1986	126	0.010	Why?
Mammary Glands, Human	1	2006	81	0.010	Why?
Chromatin Immunoprecipitation	1	2005	233	0.010	Why?
Raloxifene Hydrochloride	1	1985	16	0.010	Why?
Risk	2	1998	739	0.010	Why?
Confidence Intervals	1	2005	272	0.010	Why?
Medroxyprogesterone Acetate	1	1985	21	0.010	Why?
Research Support as Topic	1	2005	61	0.010	Why?
Drug Evaluation, Preclinical	1	1984	152	0.010	Why?
Guinea Pigs	1	1984	157	0.010	Why?
Nafoxidine	1	1984	4	0.010	Why?
Phlebitis	1	1984	1	0.010	Why?
Chickens	1	1984	286	0.010	Why?
Growth Hormone	1	1984	127	0.010	Why?
Radiotherapy	1	2004	120	0.010	Why?
Patient Care Planning	1	2005	123	0.010	Why?
Binding Sites	1	2006	1202	0.010	Why?
Rabbits	1	1984	633	0.010	Why?
Dogs	1	2005	630	0.010	Why?
Analgesics, Opioid	1	1989	470	0.010	Why?
Leydig Cell Tumor	1	1983	7	0.010	Why?
Hypercalcemia	1	1983	42	0.010	Why?
Species Specificity	1	1984	519	0.010	Why?
Protein Isoforms	1	2004	421	0.010	Why?
Megestrol Acetate	1	2003	2	0.010	Why?
Thiotepa	1	2003	18	0.010	Why?
Editorial Policies	1	2004	49	0.010	Why?
Bone Resorption	1	1983	50	0.010	Why?
RNA, Small Interfering	1	2005	665	0.010	Why?
Toremifene	1	2003	1	0.010	Why?
Genotype	1	2009	2656	0.010	Why?
Reproducibility of Results	1	2010	2991	0.010	Why?
Case-Control Studies	1	2010	3451	0.010	Why?
Mastectomy, Modified Radical	1	2003	7	0.010	Why?
Glyceraldehyde-3-Phosphate Dehydrogenase (NADP+)(Phosphorylating)	1	2002	1	0.010	Why?
Piperidines	1	1985	231	0.010	Why?
Culture Media, Serum-Free	1	2002	23	0.010	Why?
Genes, Neoplasm	1	2003	80	0.010	Why?
Antibody Specificity	1	2003	201	0.010	Why?
Incidence	1	2010	3349	0.010	Why?
Transplantation, Autologous	1	2003	269	0.010	Why?
In Situ Hybridization, Fluorescence	1	2004	755	0.010	Why?
Progesterone	1	1985	446	0.010	Why?
Thyroid Hormones	1	2003	56	0.010	Why?
Cause of Death	1	2005	510	0.010	Why?
Neoplastic Stem Cells	1	1985	329	0.010	Why?
Antigens, Neoplasm	1	2005	405	0.010	Why?
Cell Differentiation	1	1989	1948	0.010	Why?
Thrombocytopenia	1	1983	222	0.010	Why?
Acetates	2	1979	83	0.010	Why?
Spinal Cord Compression	1	1982	31	0.010	Why?
Hemagglutinins	1	2001	25	0.010	Why?
Severity of Illness Index	1	2010	3093	0.010	Why?
Anaphylaxis	1	1983	91	0.010	Why?
Chromosomes, Artificial, Yeast	1	2001	42	0.010	Why?
Physical Chromosome Mapping	1	2001	55	0.010	Why?
NM23 Nucleoside Diphosphate Kinases	1	2001	4	0.010	Why?
Expressed Sequence Tags	1	2001	80	0.010	Why?
Cyclin D1	1	2001	109	0.010	Why?
Regression Analysis	2	1998	773	0.010	Why?
Chromosomes, Artificial, Bacterial	1	2001	90	0.010	Why?
Receptors, Glucocorticoid	2	1979	105	0.010	Why?
Swine	1	1984	1190	0.010	Why?
Precancerous Conditions	1	2003	283	0.010	Why?
Antigens, Nuclear	1	2001	52	0.010	Why?
Menstruation	1	1980	26	0.010	Why?
Drug Therapy, Combination	2	1981	1170	0.010	Why?
Rodentia	1	1980	50	0.010	Why?
Luminescent Proteins	1	2000	157	0.010	Why?
Microsatellite Repeats	1	2001	232	0.010	Why?
Cell Count	1	1980	217	0.010	Why?
Macromolecular Substances	1	2000	141	0.010	Why?
COS Cells	1	2000	249	0.010	Why?
Mitotic Index	1	1999	17	0.010	Why?
CpG Islands	1	2001	338	0.010	Why?
Lymphoma, Non-Hodgkin	2	1983	163	0.010	Why?
Blood-Brain Barrier	1	2000	150	0.010	Why?
Thymidine Kinase	1	1979	89	0.010	Why?
Epithelial Cells	1	2003	900	0.010	Why?
Precipitin Tests	1	1999	137	0.010	Why?
Green Fluorescent Proteins	1	2000	382	0.010	Why?
Leucine	1	1980	262	0.010	Why?
Molecular Probe Techniques	1	1999	23	0.010	Why?
Cyclin-Dependent Kinase Inhibitor p21	1	1999	82	0.010	Why?
Lipids	1	1983	565	0.010	Why?
Reagent Kits, Diagnostic	1	1999	52	0.010	Why?
Mutagens	1	1999	48	0.010	Why?
Adenocarcinoma, Mucinous	1	1999	39	0.010	Why?
Mortality	1	1980	261	0.010	Why?
DNA Mutational Analysis	1	2001	803	0.010	Why?
Genetic Predisposition to Disease	1	2010	3416	0.010	Why?
Calcium-Calmodulin-Dependent Protein Kinases	1	1999	107	0.010	Why?
Estradiol Congeners	1	1978	3	0.010	Why?
Testosterone Congeners	1	1978	15	0.010	Why?
Fluoxymesterone	1	1998	1	0.010	Why?
Nucleic Acid Hybridization	1	1999	299	0.010	Why?
Receptors, Androgen	2	1979	419	0.010	Why?
DNA, Complementary	1	1999	436	0.010	Why?
Mice, Transgenic	1	2003	2363	0.010	Why?
Protein Structure, Tertiary	1	2000	723	0.010	Why?
Oxygen	2	1973	553	0.010	Why?
Nuclear Receptor Co-Repressor 2	1	1998	32	0.010	Why?
Preoperative Care	1	2000	358	0.010	Why?
Neuromuscular Diseases	1	1998	48	0.010	Why?
Breast Diseases	1	1998	38	0.010	Why?
Radiotherapy, Adjuvant	1	1998	155	0.010	Why?
Neoplasms, Multiple Primary	1	1998	62	0.010	Why?
Actuarial Analysis	2	1992	27	0.010	Why?
Hematologic Diseases	1	1998	82	0.010	Why?
Drug Hypersensitivity	1	1998	97	0.010	Why?
Genes, Reporter	1	1998	350	0.010	Why?
Mitomycin	1	1997	48	0.010	Why?
Temperature	1	1978	294	0.010	Why?
Osteosarcoma	1	2000	265	0.010	Why?
Hydrogen-Ion Concentration	1	1978	428	0.010	Why?
Dactinomycin	1	1976	48	0.010	Why?
Repetitive Sequences, Nucleic Acid	1	1997	351	0.010	Why?
Aging	1	1984	1266	0.010	Why?
Glucose	2	1983	848	0.010	Why?
Pain Measurement	1	1998	355	0.010	Why?
Ascites	1	1997	99	0.010	Why?
Intracellular Signaling Peptides and Proteins	1	1999	588	0.010	Why?
Registries	1	2003	1597	0.010	Why?
Income	1	1996	135	0.010	Why?
Cell Fractionation	1	1995	23	0.010	Why?
Metaphase	1	1995	31	0.010	Why?
Pleural Effusion, Malignant	1	1995	13	0.010	Why?
Heterozygote	1	1998	728	0.010	Why?
Tomography, Emission-Computed	1	1995	36	0.010	Why?
Educational Status	1	1996	281	0.010	Why?
Testicular Neoplasms	1	1976	123	0.010	Why?
Buffers	1	1995	29	0.010	Why?
Multicenter Studies as Topic	1	1996	300	0.010	Why?
Tomography, Emission-Computed, Single-Photon	1	1995	101	0.010	Why?
Receptors, Urokinase Plasminogen Activator	1	1995	25	0.010	Why?
National Institutes of Health (U.S.)	1	1995	135	0.010	Why?
Suppositories	1	1994	3	0.010	Why?
Gastrointestinal Diseases	1	1998	341	0.010	Why?
GRB7 Adaptor Protein	1	1994	2	0.010	Why?
Residence Characteristics	1	1996	293	0.010	Why?
Heart Diseases	1	1998	505	0.010	Why?
Hemoglobinuria	1	1973	2	0.010	Why?
Enzyme-Linked Immunosorbent Assay	1	1995	792	0.010	Why?
Oligonucleotides, Antisense	1	1993	73	0.010	Why?
Sequence Homology, Amino Acid	1	1994	625	0.010	Why?
Catalase	1	1973	64	0.010	Why?
Nitrites	1	1973	48	0.010	Why?
Image Processing, Computer-Assisted	1	1995	613	0.010	Why?
Lymphoma, Follicular	2	1983	32	0.010	Why?
Diet	1	1979	1119	0.010	Why?
Ultraviolet Rays	1	1973	195	0.010	Why?
Caenorhabditis elegans	1	1994	251	0.010	Why?
Sodium	1	1973	281	0.010	Why?
Ovarian Neoplasms	1	1995	455	0.010	Why?
Chromosome Mapping	1	1994	1069	0.010	Why?
Atmospheric Pressure	1	1970	5	0.010	Why?
Carcinoma, Hepatocellular	1	2000	998	0.010	Why?
Adrenal Glands	1	1970	46	0.010	Why?
Mass Spectrometry	1	1992	359	0.010	Why?
Aerospace Medicine	1	1970	39	0.010	Why?
Splenectomy	1	1970	62	0.010	Why?
Spleen	1	1970	256	0.000	Why?
Postoperative Care	1	1992	303	0.000	Why?
Blotting, Northern	1	1989	236	0.000	Why?
Leukocytes	1	1970	211	0.000	Why?
Genes, ras	1	1989	99	0.000	Why?
Ascitic Fluid	1	1988	29	0.000	Why?
Stress, Physiological	1	1970	262	0.000	Why?
Adrenal Cortex Hormones	1	1970	339	0.000	Why?
Proto-Oncogene Proteins c-myc	1	1989	195	0.000	Why?
Surveys and Questionnaires	1	1998	4052	0.000	Why?
Pleural Effusion	1	1988	106	0.000	Why?
Alopecia	1	1985	41	0.000	Why?
Vomiting	1	1985	105	0.000	Why?
Autopsy	1	1983	119	0.000	Why?
Infusions, Parenteral	1	1983	78	0.000	Why?
Deoxyglucose	1	1983	42	0.000	Why?
Endocrine Glands	1	1982	8	0.000	Why?
Phospholipids	1	1983	103	0.000	Why?
Methods	1	1982	115	0.000	Why?
Autoradiography	1	1982	65	0.000	Why?
B-Lymphocytes	1	1983	529	0.000	Why?
Cell Separation	1	1981	222	0.000	Why?
Eggs	1	1979	22	0.000	Why?
Steroids	1	1980	172	0.000	Why?
Milk	1	1979	108	0.000	Why?
Calcium	1	1983	1041	0.000	Why?
Dietary Fats	1	1979	276	0.000	Why?
Acute Disease	1	1980	1153	0.000	Why?
Prolactin	1	1977	112	0.000	Why?
Energy Intake	1	1979	501	0.000	Why?
Androgen Antagonists	1	1977	114	0.000	Why?
Lactation	1	1977	197	0.000	Why?
Androgens	1	1977	272	0.000	Why?
T-Lymphocytes	1	1983	1790	0.000	Why?
Heart Failure	1	1985	2307	0.000	Why?
Child	1	1983	26307	0.000	Why?

OSBORNE's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (725)

Explore

Co-Authors (15)

Explore

Similar People (60)

Explore

Same Department

Explore

Physical Neighbors